Currently submitted to: Journal of Participatory Medicine
Date Submitted: May 12, 2019
Open Peer Review Period: May 15, 2019 - Jul 10, 2019
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer-review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer-Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Patient Satisfaction Outcomes Following Antibiotic Resistance Education for Adults in Primary Care: A Quasi-Experimental Study
Antibiotics have saved many lives since their discovery, but today, due to their overuse, are becoming less effective. A portion of provider reimbursement from Medicare and Medicaid is based on patient satisfaction. Because of the previous effectiveness of antibiotics, patients have come to expect them from their provider when being seen for bronchitis, sinusitis, otitis media, and pharyngitis. Evidence suggests that educating patients, utilizing shared decision-making strategies, and communicating the reason for or against antibiotic prescriptions can produce positive outcomes when treating upper respiratory infections.
The purpose of this evidence-based quality initiative which employs a quasi-experimental pre- and post- design is to determine if patient education and shared decision-making with regards to pharmacologic treatment for adults with upper respiratory infections will increase patient satisfaction in a primary care clinic setting in urban Kansas.
Antibiotic resistance education was provided to 64 participants who are over the age of 18 and present to the clinic with upper respiratory complaints. Patient satisfaction will be measured with the Consumer Assessment of Healthcare Providers and Systems survey and compared to results from 61 participants who were treated for upper respiratory complaints prior to implementation of the standardized educational intervention.
Evidence suggests the two groups were not comparable (p=0.02). The evidence-based quality improvement initiative proved successful at increasing patient satisfaction in two areas, the antibiotic resistance education was recommended to the clinic for adoption as standard of care for patients with upper respiratory complaints.
The EBQI has potential to decrease inappropriate antibiotic use and improve healthcare consumer satisfaction at the local level. A similar model of education and shared decision-making could be applied to other clinical problems in the future.
Request queued. Please wait while the file is being generated. It may take some time.
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.